HCW Biologics (HCWB) FCF Margin (2022 - 2025)
HCW Biologics' (HCWB) quarterly FCF Margin came in at 12423.24% in Q4 2025, down 1167647.0% YoY from N/an in Q4 2024, and up 40.16% on a QoQ basis from 20760.87% in Q3 2025.
HCW Biologics (HCWB) FCF Margin (2022 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 4 years of FCF Margin data on file, last reported at 12423.24% in Q4 2025.
- Quarterly FCF Margin fell 1167647.0% year-over-year to 12423.24% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 24693.66% (down 2412918.0% YoY) and the FY2025 annual result came in at 24693.2%, down 2412872.0% from the prior year.
- FCF Margin grew to 12423.24% in Q4 2025, from 20760.87% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 478.34% in Q4 2022 to a low of 69375.24% in Q1 2025.
- A 4-year average of 10472.59% and a median of 693.56% in 2022 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2024 — FCF Margin soared 817218 bps — and 2025, when it plunged 6886081 bps.
- Tracing HCWB's FCF Margin over 4 years: stood at 478.34% in 2022, then tumbled by 195 bps to 456.17% in 2023, then tumbled by 64 bps to 746.77% in 2024, then slumped by 1564 bps to 12423.24% in 2025.
- The last three FCF Margin figures came in at 12423.24% (Q4 2025), 20760.87% (Q3 2025), and 50111.5% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | HCW Biologics | 2.93 Mn | 2.19 Mn | -93,887.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12,423.24% |
| Sep 30, 2025 | -20,760.87% |
| Jun 30, 2025 | -50,111.50% |
| Mar 31, 2025 | -69,375.24% |
| Dec 31, 2024 | -746.77% |
| Sep 30, 2024 | -694.98% |
| Jun 30, 2024 | -449.39% |
| Mar 31, 2024 | -514.43% |
| Dec 31, 2023 | -456.17% |
| Sep 30, 2023 | -683.16% |
| Jun 30, 2023 | -1,806.14% |
| Mar 31, 2023 | -8,686.61% |
| Dec 31, 2022 | 478.34% |
| Sep 30, 2022 | -692.15% |
| Jun 30, 2022 | -587.29% |
| Mar 31, 2022 | -51.83% |